References 44 and 52 are the first studies to systematically analyse the prevalence of MET exon 14 deletion across tumour types, finding the highest frequency in lung cancer
This review compiles the recent evidence that MET also promotes resistance to chemotherapeutic agents
BPC-157 pentadecapeptide for tissue repair, angiogenesis and gut-brain axis research 5mg lyophilised vial
(8)Fmoc-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin (8) Preparation of Fmoc-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin (7)Fmoc-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin(20DMF)5203DMF3DMF2Fmoc-Pro-OH0.8gDIEA0.4mlTBTU0.56gHOBT0.2gDMF10ml 1.53DMF3DMF2Fmoc-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin In the Fmoc-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin of step (7), add decapping reagent (DMF solution of 20% piperidine), react at room temperature for 5 minutes, pump Dry, re-add the capping agent and react at room temperature for 20 minutes, wash with isopropanol for 3 times, DMF for 3 times, re-distilled DMF for 2 times, drain, add Fmoc-Pro-OH0.8g, DIEA0.4ml, TBTU0 .56g, HOBT0.2g, DMF10ml, reacted at room temperature for 1.5 hours, dried with a vacuum pump, washed 3 times with isopropanol, washed 3 times with DMF, washed 2 times with re-distilled DMF, and dried to obtain Fmoc-Pro-Ala- Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin
